Small-molecule therapeutics
Genuv's research and development includes small-molecule drugs for neurodegenerative diseases, targeting neurogenesis and neural homeostasis.
Source: LinkedIn company description · Retrieved October 13, 2026
Genuv is a South Korean clinical-stage biopharmaceutical company focused on discovering and developing therapeutics using its drug discovery platform technologies.
The company advances its platform technologies and collaborates with external partners.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Genuv's research and development includes small-molecule drugs for neurodegenerative diseases, targeting neurogenesis and neural homeostasis.
Source: LinkedIn company description · Retrieved October 13, 2026
Genuv's research and development also includes antibody drugs for immuno-oncology treatment.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026, September 19, 2026, October 7, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.